Home › NDC Lookup › Drug shortages › Ivabradine Hydrochloride Tablet

Ivabradine Hydrochloride Tablet shortage

Ivabradine Hydrochloride Tablet is currently listed in shortage by the FDA. The FDA lists 2 affected products. This page was last refreshed from FDA data on Sep 28, 2026.

To Be Discontinued ⚠ Supply risk: High Cardiovascular 2 products 188 days First posted Mar 24, 2026 Updated Mar 24, 2026
Here’s the bottom line

Amgen is permanently stopping its ivabradine tablets. The same medicine in both strengths (5 mg and 7.5 mg) is still listed as available from other manufacturers, so supply may be found elsewhere.

Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).

Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →
2
Affected NDCs
1
Reporting manufacturers
0/1
Reporting mfrs supplying
0/2
Affected strengths supplied
188
Days in shortage
6,674
Medicaid Rx (2025)
Source: FDA Drug Shortages Database API (openFDA). Last refreshed Sep 28, 2026 · today

What’s in shortage — at a glance

These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Ivabradine Hydrochloride Tablet. Other makers that haven’t reported a problem are shown in the green card below.

Availability of affected NDCs
From the FDA shortage report
2 NDCs
To be discontinued 2
Affected strengths still supplied
Among manufacturers reporting this shortage
0/2 strengths
No supply 2
FDA-reporting manufacturers with supply
Among manufacturers reporting this shortage
0/1 makers
No supply 1
✓ Other manufacturers not reporting a shortage
Still-marketed Ivabradine Hydrochloride Tablet from companies that have not filed an FDA shortage — these are not counted in the figures above. Stock can still vary by pharmacy.
Camber Pharmaceuticals, Inc. Ingenus Pharmaceuticals, LLC Golden State Medical Supply, Inc. Amgen Inc American Health Packaging Alembic Pharmaceuticals Inc. Bionpharma Inc.
Plus 1 alternative dosage form of Ivabradine Hydrochloride.
See all other options & details →
Shortage timeline
  1. Mar 24, 2026
    Currently in shortage
    2 of 2 products affected.
  2. Mar 24, 2026
    First reported to the FDA
    2 products first listed.

Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.

What exactly is on backorder — by manufacturer

Manufacturer: Amgen Inc. 📞 1-800-772-6436 2 NDCS click to expand
Status NDC / product Strength Availability Related information Reason
To Be Discontinued Corlanor, Tablet, eq. 5 mg base (NDC 55513-800-60) NDC 55513-0800-60 — — Discontinuation of the manufacture of the drug product —
To Be Discontinued Corlanor, Tablet, eq. 7.5 mg base (NDC 55513-810-60) NDC 55513-0810-60 — — Discontinuation of the manufacture of the drug product —

These rows are manufacturer reports to the FDA for Ivabradine Hydrochloride Tablet — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Ivabradine Hydrochloride Tablet? options further down this page.

Why is Ivabradine Hydrochloride Tablet in shortage?

Amgen has reported to the FDA that they are permanently stopping the manufacturing of their brand-name version of ivabradine, Corlanor. This affects both the 5 mg and 7.5 mg tablets — specifically the 60-count bottles of each strength. Amgen did not share a specific public reason for why they made this decision.

It's worth knowing that this report covers only Amgen's Corlanor product. Other manufacturers may make their own versions of ivabradine and are listed separately on this page, so this does not necessarily mean ivabradine as a whole is going away.

Based on the manufacturer-reported reason(s) and notes on file with the FDA for Ivabradine Hydrochloride Tablet, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.

What should I do if I take Ivabradine Hydrochloride Tablet?

Ivabradine hydrochloride tablets are currently on the FDA drug-shortage list. I want to walk you through what this means so you can plan your next step calmly.

Both strengths of the brand-name Corlanor tablets — the 5 mg and the 7.5 mg — are affected, and neither has an available source right now. The reason listed is that the manufacturer, Amgen, is discontinuing the manufacture of this product. Because this is a discontinuation rather than a temporary delay, this particular supply may not return, so a conversation with your prescriber is the right next step.

The important point is that ivabradine, the medicine itself, is still made by other companies. Several manufacturers — including Camber, Ingenus, Golden State, Alembic, and Bionpharma — list the same ingredient in both the 5 mg and 7.5 mg tablet. This is the same medicine, just from a different maker. It may not be sitting on your local pharmacy's shelf, but your pharmacy can often order it.

Here is what I suggest:

  1. Do not stop, skip, or change your dose on your own.
  2. Ask your pharmacy to source ivabradine from one of the other manufacturers listed above; they can check wholesalers.
  3. If it cannot be found, ask your prescriber or pharmacist about options.

Manufacturer contact numbers are on this page for reference; pharmacies usually handle those calls. This is national, manufacturer-reported data and may not match your local stock.

See “Where else can I get Ivabradine Hydrochloride Tablet?” below ↓ The same medicine from manufacturers not reporting a shortage, alternative dosage forms, and therapeutic equivalents with pricing.
If you are a patient:
  • Don’t stop or change the medication on your own — talk to your prescriber first.
  • If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
  • Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
  • Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Keep reading
Our full Ivabradine guide

Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.

Read the Ivabradine guide →

Where else can I get Ivabradine Hydrochloride Tablet?

FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Ivabradine Hydrochloride Tablet is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.

Same medicine, other manufacturers (not reported short)

Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:

ProductStrengthForm / routeManufacturerNDC
Ivabradine IVABRADINE HYDROCHLORIDE 5 mg/1 Tablet, Film Coated · Oral Camber Pharmaceuticals, Inc. 31722-0053-60
Ivabradine IVABRADINE HYDROCHLORIDE 7.5 mg/1 Tablet, Film Coated · Oral Camber Pharmaceuticals, Inc. 31722-0054-60
Ivabradine IVABRADINE HYDROCHLORIDE 5 mg/1 Tablet, Film Coated · Oral Ingenus Pharmaceuticals, LLC 50742-0362-60
Ivabradine IVABRADINE HYDROCHLORIDE 7.5 mg/1 Tablet, Film Coated · Oral Ingenus Pharmaceuticals, LLC 50742-0363-60
Ivabradine IVABRADINE HYDROCHLORIDE 5 mg/1 Tablet, Film Coated · Oral Golden State Medical Supply, Inc. 51407-0592-60
Ivabradine IVABRADINE HYDROCHLORIDE 7.5 mg/1 Tablet, Film Coated · Oral Golden State Medical Supply, Inc. 51407-0593-60
Corlanor IVABRADINE HYDROCHLORIDE 5 mg/1 Tablet, Film Coated · Oral Amgen Inc 55513-0800-99
Ivabradine IVABRADINE HYDROCHLORIDE 5 mg/1 Tablet, Film Coated · Oral American Health Packaging 60687-0862-21
Ivabradine IVABRADINE HYDROCHLORIDE 5 mg/1 Tablet, Film Coated · Oral Alembic Pharmaceuticals Inc. 62332-0679-45
Ivabradine IVABRADINE HYDROCHLORIDE 7.5 mg/1 Tablet, Film Coated · Oral Alembic Pharmaceuticals Inc. 62332-0680-45
Ivabradine IVABRADINE HYDROCHLORIDE 5 mg/1 Tablet, Film Coated · Oral Bionpharma Inc. 69452-0190-17
Ivabradine IVABRADINE HYDROCHLORIDE 7.5 mg/1 Tablet, Film Coated · Oral Bionpharma Inc. 69452-0191-17

Alternative dosage forms of Ivabradine Hydrochloride

A different form of the same drug (for example a solution when capsules are short). A form change is a clinical decision — ask your prescriber:

Therapeutic equivalents & pricing 23 productsclick to expand

Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.

ProductManufacturerPackageNADAC $/unitAB ratingAvailability
Ivabradine 7.5 mgNDC 31722-0054-60 Camber 60 tablets $0.640 save 94% AB Availability likely
Ivabradine 7.5 mgNDC 50742-0363-60 Ingenus 60 tablets $0.640 save 94% AB Availability likely
ivabradine 7.5 mgNDC 69452-0191-17 Bionpharma 60 tablets $0.640 save 94% AB Availability likely
ivabradine 7.5 mgNDC 70710-1472-06 Zydus 60 tablets $0.640 save 94% AB Availability likely
Ivabradine 7.5 mgNDC 72603-0935-01 Northstar 60 tablets $0.640 save 94% AB Availability likely
Ivabradine 5 mgNDC 31722-0053-60 Camber 60 tablets $0.761 save 92% AB Availability likely
Ivabradine 5 mgNDC 50742-0362-60 Ingenus 60 tablets $0.761 save 92% AB Availability likely
Ivabradine 5 mgNDC 60687-0862-21 American 1 tablet $0.761 save 92% AB Availability likely
ivabradine 5 mgNDC 69452-0190-17 Bionpharma 60 tablets $0.761 save 92% AB Availability likely
ivabradine 5 mgNDC 70710-1471-06 Zydus 60 tablets $0.761 save 92% AB Availability likely
Ivabradine 5 mgNDC 72603-0934-01 Northstar 60 tablets $0.761 save 92% AB Availability likely
Corlanor 7.5 mgNDC 55513-0810-60 Amgen 60 tablets $9.998 — Availability likely
Corlanor 5 mgNDC 55513-0800-60 Amgen 60 tablets $10.011 — Availability likely
Ivabradine 5 mgNDC 46708-0679-45 Alembic 180 tablets — AB FDA listed
Ivabradine 5 mgNDC 51407-0592-60 Golden 60 tablets — AB FDA listed
Ivabradine 5 mgNDC 62332-0679-45 Alembic 180 tablets — AB FDA listed
ivabradine 5 mgNDC 70771-1863-06 Zydus 60 tablets — AB FDA listed
Ivabradine 5 mgNDC 72205-0336-18 Novadoz 180 tablets — AB FDA listed
Ivabradine 7.5 mgNDC 46708-0680-45 Alembic 180 tablets — AB FDA listed
Ivabradine 7.5 mgNDC 51407-0593-60 Golden 60 tablets — AB FDA listed
Ivabradine 7.5 mgNDC 62332-0680-45 Alembic 180 tablets — AB FDA listed
ivabradine 7.5 mgNDC 70771-1864-06 Zydus 60 tablets — AB FDA listed
Ivabradine 7.5 mgNDC 72205-0337-18 Novadoz 180 tablets — AB FDA listed

Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.

Identity & classification

GCN Seq No 060186
GCN 26238
HICL code 033396
Ingredient (HICL) Ivabradine Hcl
HIC1 code A
Therapeutic class — broad (HIC1) Cardiovascular System
HIC2 code A2
Therapeutic class — intermediate (HIC2) Cardiac Depressants
HIC3 code A2B
Therapeutic class — specific (HIC3) Heart Rate Reducing,Sa Selective I(F) Current Inh.
AHFS code 24:04.08.00
AHFS class Cardiotonic Agents
FDB label name CORLANOR 5 MG TABLET
FDB brand name Corlanor
Legend status F — Federal legend — prescription drug or device
GPI-1440700035100320
GPI classCorlanor
Where does this data come from?
Identity codes come from First Databank (FDB) (HICL ingredient, HIC1–3 therapeutic-class hierarchy, GCN, AHFS class, legend status) and Medi-Span GPI, mapped from a representative affected NDC. Licensed reference data — for identification only.

Other cardiovascular shortages

Ivabradine Hydrochloride Tablet shortage FAQs

Is Ivabradine Hydrochloride Tablet in shortage?
Yes — the FDA currently lists Ivabradine Hydrochloride Tablet in shortage (status: “To Be Discontinued”, first reported Mar 24, 2026). 2 of 2 products are affected. This is national, manufacturer-reported data, so your pharmacy may still have stock.
Which products are affected?
Corlanor, Tablet, eq. 5 mg base (NDC 55513-800-60) (NDC 55513-0800-60); Corlanor, Tablet, eq. 7.5 mg base (NDC 55513-810-60) (NDC 55513-0810-60). The full per-NDC list (availability, manufacturer and status) is in the table above — each NDC links to its own page.
When will Ivabradine Hydrochloride Tablet be available again?
The FDA does not publish a guaranteed restock date, and no estimated-recovery note is on file. Availability can change daily — confirm with your pharmacy.
Can I still get Ivabradine Hydrochloride somewhere?
Other manufacturers (Camber Pharmaceuticals, Inc., Ingenus Pharmaceuticals, LLC, Golden State Medical Supply, Inc. and others) still market it and have not reported a shortage. 1 alternative dosage form of Ivabradine Hydrochloride is also listed. See “Where else can I get Ivabradine Hydrochloride Tablet?” above — stock still varies by pharmacy.
What should I do if I take Ivabradine Hydrochloride Tablet?
Don’t stop or change it on your own. Ask your pharmacist whether they can order it from another manufacturer or a different strength/package size, and ask your prescriber about a long-term plan before your supply runs out.

Still have a question about the Ivabradine Hydrochloride Tablet shortage?

Ask a pharmacist about this shortage →
How to read the Supply-Risk rating
Low (1–2)Multiple manufacturers still supplying and most strengths or pack sizes sourceable.
Medium (3)Some constraint — fewer suppliers or a notable share of NDCs unavailable.
High (4–5)Down to a single source, most strengths or pack sizes unsourceable, or a long-running outage.
Where does this data come from?
Shortage records come from the FDA Drug Shortages Database API via openFDA (/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.
Data structure & sourcing designed and verified by Dr. Brian Staiger, PharmD.
← Back to all current drug shortages